$101 Million is the total value of AlphaCentric Advisors LLC's 165 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $1,250,910 | – | 27,000 | +100.0% | 1.24% | – |
ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $1,161,800 | – | 78,500 | +100.0% | 1.15% | – |
ADCT | New | ADC THERAPEUTICS SA | $1,142,400 | – | 297,500 | +100.0% | 1.13% | – |
NVAX | New | NOVAVAX INC | $1,079,400 | – | 105,000 | +100.0% | 1.07% | – |
DX | New | DYNEX CAP INC | $1,063,265 | – | 83,590 | +100.0% | 1.05% | – |
New | MOBILEYE GLOBAL INC | $876,500 | – | 25,000 | +100.0% | 0.87% | – | |
LNTH | New | LANTHEUS HLDGS INC | $866,320 | – | 17,000 | +100.0% | 0.86% | – |
New | CINCOR PHARMA INC | $860,300 | – | 70,000 | +100.0% | 0.85% | – | |
ACAD | New | ACADIA PHARMACEUTICALS INC | $796,000 | – | 50,000 | +100.0% | 0.79% | – |
New | DOCGO INC | $777,700 | – | 110,000 | +100.0% | 0.77% | – | |
PCRX | New | PACIRA BIOSCIENCES INC | $733,590 | – | 19,000 | +100.0% | 0.72% | – |
MRTX | New | MIRATI THERAPEUTICS INC | $634,340 | – | 14,000 | +100.0% | 0.63% | – |
EXEL | New | EXELIXIS INC | $529,320 | – | 33,000 | +100.0% | 0.52% | – |
New | NUVALENT INC | $461,590 | – | 15,500 | +100.0% | 0.46% | – | |
CI | New | CIGNA CORP NEW | $426,435 | – | 1,287 | +100.0% | 0.42% | – |
New | ZYMEWORKS DEL INC | $412,650 | – | 52,500 | +100.0% | 0.41% | – | |
INSM | New | INSMED INC | $399,600 | – | 20,000 | +100.0% | 0.40% | – |
ITCI | New | INTRA CELLULAR THERAPIES INC | $396,900 | – | 7,500 | +100.0% | 0.39% | – |
TVTX | New | TRAVERE THERAPEUTICS INC | $391,999 | – | 18,640 | +100.0% | 0.39% | – |
INMD | New | INMODE LTD | $357,000 | – | 10,000 | +100.0% | 0.35% | – |
MDT | New | MEDTRONIC PLC | $310,880 | – | 4,000 | +100.0% | 0.31% | – |
MRO | New | MARATHON OIL CORP | $301,641 | – | 11,143 | +100.0% | 0.30% | – |
AFL | New | AFLAC INC | $284,451 | – | 3,954 | +100.0% | 0.28% | – |
GL | New | GLOBE LIFE INC | $284,257 | – | 2,358 | +100.0% | 0.28% | – |
JNJ | New | JOHNSON & JOHNSON | $281,933 | – | 1,596 | +100.0% | 0.28% | – |
MCK | New | MCKESSON CORP | $278,714 | – | 743 | +100.0% | 0.28% | – |
PGR | New | PROGRESSIVE CORP OHIO | $278,487 | – | 2,147 | +100.0% | 0.28% | – |
JKHY | New | HENRY JACK & ASSOC INC | $268,958 | – | 1,532 | +100.0% | 0.27% | – |
GPC | New | GENUINE PARTS CO | $267,032 | – | 1,539 | +100.0% | 0.26% | – |
CVX | New | CHEVRON CORP NEW | $262,594 | – | 1,463 | +100.0% | 0.26% | – |
AMGN | New | AMGEN INC | $260,539 | – | 992 | +100.0% | 0.26% | – |
BMY | New | BRISTOL MYERS SQUIBB CO | $253,120 | – | 3,518 | +100.0% | 0.25% | – |
EQT | New | EQT CORP | $230,619 | – | 6,817 | +100.0% | 0.23% | – |
EOG | New | EOG RES INC | $165,008 | – | 1,274 | +100.0% | 0.16% | – |
PMO | New | PUTNAM MUN OPPORTUNITIES TRsh ben int | $160,797 | – | 14,820 | +100.0% | 0.16% | – |
MQY | New | BLACKROCK MUNIYILD QULT FD I | $116,000 | – | 10,000 | +100.0% | 0.12% | – |
SAFE | New | SAFEHOLD INC | $110,874 | – | 3,874 | +100.0% | 0.11% | – |
OVV | New | OVINTIV INC | $108,824 | – | 2,146 | +100.0% | 0.11% | – |
AR | New | ANTERO RES CORP | $108,558 | – | 3,503 | +100.0% | 0.11% | – |
UAL | New | UNITED CONTL HLDGS INC | $89,123 | – | 2,364 | +100.0% | 0.09% | – |
HES | New | HESS CORP | $56,870 | – | 401 | +100.0% | 0.06% | – |
ALB | New | ALBEMARLE CORP | $45,541 | – | 210 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HORIZON THERAPEUTICS PUB L | 12 | Q3 2023 | 2.9% |
INTUITIVE SURGICAL INC | 12 | Q3 2023 | 1.3% |
STEREOTAXIS INC | 12 | Q3 2023 | 1.0% |
ALLIED MOTION TECHNOLOGIES I | 12 | Q3 2023 | 1.3% |
AEROVIRONMENT INC | 12 | Q3 2023 | 1.3% |
OMNICELL COM | 12 | Q3 2023 | 0.9% |
ACCURAY INC | 12 | Q3 2023 | 0.8% |
COLLEGIUM PHARMACEUTICAL INC | 12 | Q3 2023 | 1.1% |
MICROBOT MED INC | 12 | Q3 2023 | 0.5% |
ISHARES TR | 11 | Q3 2023 | 13.1% |
View AlphaCentric Advisors LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-24 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-13 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-08 |
13F-HR | 2022-03-11 |
13F-HR | 2022-03-11 |
View AlphaCentric Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.